CytoJournal Information

CytoJournal is supported by an elaborate Editorial Board which includes experts with variety of expertise and interests from diverse regions of the globe. Cytopathology is a well-established diagnostic sub-specialty of pathology. Instead of using surgically removed tissue to arrive at a diagnosis it attempts to identify diagnostic and prognostic information from dispersed cells obtained by non-invasive or minimally invasive techniques. An example, and its greatest success story thus far, is the role it has played in the battle against cervical cancer. Indeed, the Pap smear introduced by George Papanicolaou has contributed immensely to the early diagnosis and significantly decreased mortality of cervical cancer. Free flow of scientific information is crucial for the advancement of disease diagnosis and management in the developed and developing world. CytoJournal as an Open Access, online journal, quality controlled through traditional peer review processes and the first of its kind in the field of cytopathology. It should positively influence the advancement of the scientific community around the world. National Institute of Health (NIH) now has a policy to mandate publication of NIH funded research in open access journals http://www.ncbi.nlm.nih.gov/PubMed/ with list of journals http://publicaccess.nih.gov/submit_process_journals.htm in which such funded research is allowed to be published. CytoJournal is the only cytopathology journal in this list. Additional benefits of an online journal include rapid turnaround time, real time publication, significant cost savings, and a reduction in the environmental burden in the production and disposal of a print publication. At present, none of the existing journals in the field of cytopathology belong to this category. Till 23rd June 2008, CytoJournal was published by BioMedCentral.